Zhejiang Ausun Pharmaceutical Co Ltd (603229) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.052x

Based on the latest financial reports, Zhejiang Ausun Pharmaceutical Co Ltd (603229) has a cash flow conversion efficiency ratio of 0.052x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥121.49 Million ≈ $17.78 Million USD) by net assets (CN¥2.35 Billion ≈ $343.48 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Zhejiang Ausun Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Zhejiang Ausun Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Zhejiang Ausun Pharmaceutical Co Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.

Zhejiang Ausun Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Ausun Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Guomai Technologies Inc SHE:002093	0.092x
Bright Real Estate Group Co Ltd SHG:600708	-0.004x
Tilaknagar Industries Limited NSE:TI	1.730x
Actions Technology Co Ltd SHG:688049	0.045x
BrightView Holdings NYSE:BV	0.020x
Castellana Properties Socimi MC:YCPS	0.050x
Zug Estates Holding AG SW:ZUGN	0.021x
Flow Traders BV AS:FLOW	-1.463x

Annual Cash Flow Conversion Efficiency for Zhejiang Ausun Pharmaceutical Co Ltd (2012–2024)

The table below shows the annual cash flow conversion efficiency of Zhejiang Ausun Pharmaceutical Co Ltd from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see Zhejiang Ausun Pharmaceutical Co Ltd stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.27 Billion ≈ $332.45 Million	CN¥177.93 Million ≈ $26.04 Million	0.078x	-24.40%
2023-12-31	CN¥2.14 Billion ≈ $313.38 Million	CN¥221.85 Million ≈ $32.46 Million	0.104x	+25.54%
2022-12-31	CN¥1.46 Billion ≈ $213.81 Million	CN¥120.57 Million ≈ $17.64 Million	0.083x	-40.46%
2021-12-31	CN¥1.25 Billion ≈ $183.62 Million	CN¥173.90 Million ≈ $25.45 Million	0.139x	+12.78%
2020-12-31	CN¥1.13 Billion ≈ $164.90 Million	CN¥138.47 Million ≈ $20.26 Million	0.123x	-9.63%
2019-12-31	CN¥645.19 Million ≈ $94.41 Million	CN¥87.73 Million ≈ $12.84 Million	0.136x	+606.38%
2018-12-31	CN¥597.60 Million ≈ $87.45 Million	CN¥11.50 Million ≈ $1.68 Million	0.019x	-76.76%
2017-12-31	CN¥564.93 Million ≈ $82.67 Million	CN¥46.78 Million ≈ $6.85 Million	0.083x	-78.38%
2016-12-31	CN¥243.30 Million ≈ $35.60 Million	CN¥93.21 Million ≈ $13.64 Million	0.383x	+34.36%
2015-12-31	CN¥188.07 Million ≈ $27.52 Million	CN¥53.63 Million ≈ $7.85 Million	0.285x	+3.96%
2014-12-31	CN¥78.21 Million ≈ $11.44 Million	CN¥21.45 Million ≈ $3.14 Million	0.274x	-42.62%
2013-12-31	CN¥32.91 Million ≈ $4.82 Million	CN¥15.73 Million ≈ $2.30 Million	0.478x	+534.85%
2012-12-31	CN¥10.36 Million ≈ $1.52 Million	CN¥-1.14 Million ≈ $-166.57K	-0.110x	--

About Zhejiang Ausun Pharmaceutical Co Ltd

SHG:603229 China Biotechnology

Market Cap

$1.25 Billion

CN¥8.51 Billion CNY

Market Cap Rank

#8225 Global

#2104 in China

Share Price

CN¥10.25

Change (1 day)

+4.27%

52-Week Range

CN¥7.97 - CN¥12.31

All Time High

CN¥1598.02